Study of the Efficacy and Safety of Somatropin in Japanese Participants With PWS

    Not Recruiting
  • End date
    Jun 1, 2024
  • participants needed
  • sponsor
Updated on 5 March 2022


This is a multicenter, open label, multi cohort study to evaluate the efficacy and safety of somatropin in a cohort of Japanese participants with PWS.

Condition Obesity, Prader-Willi Syndrome
Treatment somatropin - GH naïve pediatric cohort, somatropin - GH treated cohort, somatropin - adult cohort
Clinical Study IdentifierNCT04697381
Last Modified on5 March 2022

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note